Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase

Free Radical Biology and Medicine

Volumn 28, Issue 10, 2000, Pages 1571-1576

  Copin, Jean Christophe ^a   Gasche, Yvan ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aconitase; Antioxidant; Compartmentalization; Copper zinc superoxide dismutase; Free radicals; Knockout; Manganese superoxide dismutase; Mice; Transgenic

Indexed keywords

ACONITATE HYDRATASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; HEART MITOCHONDRION; LETHALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; FEMALE; GENE EXPRESSION; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TISSUE DISTRIBUTION;

EID: 0034656838     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00280-X     Document Type: Article

References (33)

1. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
2. Gibbons G.H., Dzau V.J. Molecular therapies for vascular diseases. Science. 272:1996;689-693.
3. Behl C. Alzheimer's disease and oxidative stress implications for novel therapeutic approaches. Prog. Neurobiol. 57:1999;301-323.
4. Ebadi M., Srinivasan S.K., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
5. Omar B.A., Flores S.C., McCord J.M. Superoxide dismutase pharmacological developments and applications. Adv. Pharmacol. 23:1992;109-161.
6. Weisiger R.A., Fridovich I. Superoxide dismutase. Organelle specificity. J. Biol. Chem. 248:1973;3582-3592.
7. Peeters-Joris C., Vandevoorde A.M., Baudhuin P. Subcellular localization of superoxide dismutase in rat liver. Biochem. J. 150:1975;31-39.
8. Slot J.W., Geuze H.J., Freeman B.A., Crapo J.D. Intracellular localization of the copper-zinc and manganese superoxide dismutase in rat liver parenchymal cells. Lab. Invest. 55:1986;363-371.
9. Crapo J.D., Oury T., Rabouille C., Slot J.W., Chang L.Y. Copper, zinc superoxide dismutase is primarly a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA. 89:1992;10405-10409.
10. Lindenau J., Noack H., Possel H., Asayama K., Wolf G. Cellular distribution of superoxide dismutase in the rat CNS. Glia. 29:2000;25-34.
11. Lebovitz R.M., Zhang H., Vogel H., Cartwright J. Jr, Dionne L., Lu N., Huang S., Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;9782-9787.
12. Li Y., Huang T.-T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11:1995;376-381.
13. Beal M.F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6:1996;661-666.
14. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18:1998;205-213.
15. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048.
16. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
17. Chan P.H., Yang G.Y., Chen S.F., Carlson E., Epstein C.J. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann. Neurol. 29:1991;482-486.
18. Juurlink B.H.J., Hertz L. Astrocytes. Boulton A.A., Baker G.B., Waltz W. Neuromethods. 1992;269-321 The Humana Press Inc, Totowa, NJ.
19. Crapo J.D., McCord J.M., Fridovich I. Preparation and assay of superoxide dismutases. Methods Enzymol. 53:1978;382-393.
20. Hausladen A., Fridovich I. Measuring nitric oxide and superoxide rate constants for aconitase reactivity. Methods Enzymol. 269:1996;37-41.
21. Amstad P., Moret R., Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu, Zn-superoxide dismutase overproducers to oxidant stress. J. Biol. Chem. 269:1994;1606-1609.
22. Bar-Pelled O., Korkotian E., Segal M., Groner Y. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. Proc. Natl. Acad. Sci. USA. 93:1996;8530-8535.
23. Fullerton H.J., Ditelberg J.S., Chen S.F., Sarco D.P., Chan P.H., Epstein C.J. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol. 44:1998;357-364.
24. Gardner P.R., Nguyen D.D., White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. USA. 91:1994;12248-12252.
25. Copin, J. C.; Li, Y.; Gasche, Y.; Calagui, B.; Hasegawa, K.; Epstein, C. J.; Chan, P. H. Loss of sensitivity to oxygen toxicity due to low oxygen pressure preconditioning in manganese-dependent superoxide dismutase knockout astrocytes. Soc. Neurosci. 24:984; 1998. (abstr.).
26. Balzan R., Bannister W.H., Hunter G.J., Bannister J.V. Escherichia coli iron superoxide dismutase targeted to the mitochondria of yeast cells protects the cells against oxidative stress. Proc. Natl. Acad. Sci. USA. 92:1995;4219-4223.
27. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease selective vulnerability of the basal ganglia. Ann. Neurol. 41:1997;646-653.
28. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44:1998;S72-S84.
29. Allen R.G. Oxidative stress and superoxide dismutase in development, aging and gene regulation. Age. 21:1998;47-76.
30. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA. 96:1999;846-851.
31. Luft R. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA. 91:1994;8731-8738.
32. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18:1998;159-163.
33. Li Y., Stansbury K.H., Zhu H., Trush M.A. Biochemical characterization of lucigenin (Bis-N-methylacridinium) as a chemiluminescent probe for detecting intramitochondrial superoxide anion radical production. Biochem. Biophys. Res. Commun. 262:1999;80-87.